- Home
- Equipment
- canada alberta
- therapeutic vaccine
Show results for
Refine by
Therapeutic Vaccine Equipment & Supplies In Alberta
34 equipment items found
Manufactured by:Transgene based inIllkirch-Graffenstaden, FRANCE
TG4001 is an innovative therapy capable of combating papillomavirus-induced cancers. The concept behind TG4001 is to teach the immune system to recognise and destroy the cancer cells expressing HPV-16 antigens, specifically E6 and E7 ...
Manufactured by:Transgene based inIllkirch-Graffenstaden, FRANCE
A particularly innovative immunotherapy, TG4050 is the lead myvac® candidate. This individualized treatment is based on the specific mutations that are identified in each patient’s ...
Manufactured by:VBI Vaccines Inc. based inCambridge, MASSACHUSETTS (USA)
VLPs can be customized to present any protein antigen, including multiple antibody and T cell targets, making them ideal technologies for the development of both prophylactic and therapeutic vaccines. Moreover, most of the emerging and re-emerging viruses that pose significant health threats are enveloped viruses, making them prime targets for VBI’s ...
Manufactured by:Auro Vaccines LLC based inPearl River, NEW YORK (USA)
Auro Vaccines is developing a GeneVav prime/VesiculoVax™ boost therapeutic vaccine that targets all HCV genotypes for use as an adjunct to drug ...
Manufactured by:Auro Vaccines LLC based inPearl River, NEW YORK (USA)
Auro Vaccines is developing a GeneVax prime/VesiculoVax boost therapeutic vaccine for herpes simplex virus type-2. This vaccine is designed to ameliorate disease and transmission by preventing HSV-2 reactivation and ...
Manufactured by:Auro Vaccines LLC based inPearl River, NEW YORK (USA)
Auro Vaccines is developing a GeneVax prime/VesiculoVax boost therapeutic HPV vaccine for use as an adjunct to surgery that targets the seven HPV types responsible for more than 92% of cervical and head and neck ...
Manufactured by:Auro Vaccines LLC based inPearl River, NEW YORK (USA)
Auro Vaccines has also developed a GeneVax prime/VesiculoVax boost therapeutic vaccine that targets all eight HBV genotypes for use as an adjunct to drug ...
Manufactured by:Vitruvian BioMedical, Inc. based inAddison, TEXAS (USA)
VITRUVIAN has obtained the Exclusive Global License for a Therapeutic Vaccine for the Prevention of Alzheimer's Disease. YM7555 - Alzheimer’s Disease Therapeutic Vaccine targeting ABeta and TAU. VITRUVIAN has received an Exclusive Global License for YM7555 which is a Therapeutic Vaccine ...
Manufactured by:ViciniVax BV based inGroningen, NETHERLANDS
Our first product candidate Vvax001, a therapeutic cancer vaccine against (pre)malignant cervical lesions, is currently in clinical development. We outsource process development and GMP manufacturing to experienced CMO’s, leading to a first clinical trial, which has been started in ...
Manufactured by:Enterome based inParis, FRANCE
OncoMimicsTM vaccines are a specific combination of bacterial peptides, derived from bacteria present in the gut microbiome, that closely mimic either overexpressed tumor-associated antigens (TAAs) or lineage-specific markers in solid and liquid tumors, respectively. ...
Manufactured by:Frontier Biotechnologies Inc. based inNanjing, CHINA
Licensed with exclusive rights for greater China from AFFiRiS AG, a clinical-stage biotechnology company in Austria, FB6001 is an investigational therapeutic peptide vaccine targeting PCSK9 to treat hypercholesterolemia. PCSK9 is a clinically validated target and FB6001 is a potential first-in-class immunotherapy for hypercholesteremia. FB6001 is expected to be ...
Manufactured by:Enterome based inParis, FRANCE
EO4010 is an innovative, off-the-shelf therapeutic cancer vaccine currently in discovery. EO4010 peptides combination will include two OncoMimics (bacterial peptides) already used in EO2401 and one or two additional peptides in an indication with high unmet medical need and market potential. ...
Manufactured by:Enterome based inParis, FRANCE
EO2463 is an innovative, off-the-shelf therapeutic cancer vaccine discovered by Enterome. EO2463 combines four OncoMimics peptides (bacterial peptides) of B lymphocyte-specific lineage markers. The clinical rationale behind targeting these specific lineage cell markers is to induce the full depletion of malignant B lymphocytes enriched in indolent non-Hodgkin ...
Manufactured by:Enterome based inParis, FRANCE
EO2401 is an innovative, off-the-shelf immunotherapy discovered by ...
Manufactured by:eTheRNA based inNiel, BELGIUM
Therapeutic area: prophylactic vaccines; Intramuscular (IM) ...
Manufactured by:eTheRNA based inNiel, BELGIUM
Therapeutic area: cancer vaccines; Systemic, intravenous (IV) ...
Manufactured by:leon-nanodrugs GmbH based inMunich, GERMANY
The closed disposable system enables aseptic processing, allowing for rapid production of individual batches without the risk of cross-contamination, and eliminates the need for cleaning and sterilization steps in between batches. NANOme is highly adaptable for clinical use in personalized medicines such as therapeutic cancer vaccines and as an adjunct to ...
Manufactured by:Ardigen based inKraków, POLAND
Quick solution for effective immune responses in clinical trials; We have created an Artificial Intelligence platform dedicated to being a part of the therapeutic cancer vaccine development. The ArdImmune Vax platform uses sequencing data to generate and prioritize antigen targets for cancer vaccines and T-cell ...
Manufactured by:Thermo Fisher Scientific based inWaltham, MASSACHUSETTS (USA)
Specifically designed to lend innovation and efficiency for highly-effective upstream or downstream applications in large-scale cell culture and production of vaccines, cell therapeutics or other biological ...
Manufactured by:Thermo Fisher Scientific based inWaltham, MASSACHUSETTS (USA)
Specifically designed to lend innovation and efficiency for highly-effective upstream or downstream applications in large-scale cell culture and production of vaccines, cell therapeutics or other biological ...